Abstract. Although non-viral vectors are relatively safe, they have very low gene transfection efficiency, especially in pancreatic islet cells. To provide information on the use of nonviral vectors for transfecting genes into pancreatic islet cells, a comparative evaluation of non-viral options was performed.
Introduction
Islet transplantation is a promising therapeutic intervention for type 1 diabetes mellitus. One of the significant obstacles to successful pancreatic islet transplantation is the high number of non-functioning islet grafts during the first few days after implantation (1) . Moreover, a significant proportion of the functioning islet grafts is gradually destroyed, presumably due to ischemic damage, instant blood-mediated inflammatory reaction (IBMIR), non-specific injuries or immune destruction (2, 3) . To overcome these obstacles and improve the outcome of islet transplantation, genetic modification of islets was attempted (4) . The choice of non-viral and viral gene delivery vectors for ex vivo gene therapy of islets prior to transplantation depends on the desired level and duration of gene expression (5) . Although non-viral vectors are relatively safe, they have very low transfection efficiency. Depending on the target gene, however, transient gene expression in a small portion of islet cells may be sufficient (1, 4, 6) .
The majority of the non-viral vectors used for gene therapy, such as non-lipid cationic polymers [polyethylenimine (PEI), polyamidoamine (PAMAM), poly-L-lysine], hemagglutinating virus of Japan-envelope (HVJ-E, an inactivated Sendai virus envelope), cationic liposomal lipid (Lipofectamine), and cationic non-liposomal lipids (Effectene), were developed for favorable transfection efficiency in gene transfer (7) (8) (9) . To our knowledge, there are very few reports on introducing foreign DNA into islets using non-viral delivery vectors (4, 6, 10, 11) .
We used a comparative approach to analyze the transfection efficiency and cytotoxicity of three classes of non-viral vectors; Effectene, PEI (25 kDa) and HVJ-E, in dividing rat insulinoma cells (INS-1) and non-dividing rat islet cells to provide information on their potential for transfecting human islet cells in vitro, and their possible applicability for human islets in vivo.
Materials and methods
Cell culture and islet isolation. INS-1 rat insulinoma cells were cultured in RPMI-1640 (11 mM glucose, 1 mM sodium pyruvate, 10 mM/l HEPES) supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin at 37˚C and in 5% CO 2 . In studies involving serum-starvation, FBS was replaced with 0.1% BSA.
Pancreatic islets were isolated from male Sprague-Dawley rats (250-300 g) by 1 mg/ml collagenase P (Roche, Indianapolis, IN) digestion, separated by discontinuous Ficoll gradient purification (Biochrom AG, Berlin, Germany), and cultured free-floating in 10 ml of Medium 199 (Gibco, Grand Island, NY). Individual islets were selected using micropipettes.
Preparation of non-viral vectors and plasmids.
To evaluate the efficiency of non-viral vectors for gene delivery into rat islet cells, three different classes of transfection reagents were chosen, Effectene (Qiagen, Valencia, CA), PEI, and HVJ-E (Cosmo Bio Co., Tokyo, Japan). pEGFP-C1 (Clontech, Palo Alto, CA) and pCMV-Luc were used as reporter plasmids. These plasmids were introduced into E. coli strain JM109 (Promega) and purified using Qiagen Plasmid Maxi Kits (Qiagen).
For the transfection assays, INS-1 cells were seeded at a density of 5.0x10
5 cells/well in 12-well plates. After 24 h, cells were washed twice with serum-free OPTI-MEM media and then 2 ml of fresh serum-free OPTI-MEM was added. Transfection conditions for Effectene/pCMV-Luc or HVJ-E/ pCMV-Luc were optimized according to the manufacturer's instructions. PEI 25K/pCMV-Luc complexes were prepared at a 5/1 nitrogen of PEI (N)/phosphate of DNA (P) ratio (12) . The amount of plasmid was fixed at 2 μg/well and the complexes of plasmid and transfection reagent were added to each well. The cells were then incubated for 15 h at 37˚C in a 5% CO 2 incubator. After the incubation, the transfection mixtures were removed and 2 ml of fresh medium containing 10% FBS was added. INS-1 cells and rat islets were also transfected with 25 μl Effectene/pEGFP-C1 complexes, or PEI 25 kDa/pEGFP-C1 complexes at 1, 2 and 4 μg DNA equivalents and incubated at 37˚C for >15 h.
Transfection efficiency
Luciferase activity. After the incubation, INS-1 cells were washed with PBS twice, and 200 μl of reporter lysis buffer (Promega, Madison, WI) was added to each dish. After 15 min of incubation at room temperature, cells were harvested and transferred to microcentrifuge tubes. After 15 sec of vortex mixing, cells were centrifuged at 13,000 rpm for 3 min. The extract was transferred to fresh tubes and stored at -70˚C until use. The protein concentration of the extract was determined by using a BCA protein assay kit (Thermo Scientific Pierce, Rockford, IL). Luciferase activity was measured in terms of relative light units (RLU) using a 96-well plate luminometer (Berthold Detection System GmbH, Pforzheim, Germany). The luciferase activity was monitored and integrated over a period of 20 sec. The final values of luciferase activity were reported in terms of RLU/mg total protein.
Measurement of GFP expression using flow cytometry and fluorescence microscope. Transfection efficiency was determined by flow cytometry using enhanced green fluorescent protein (EGFP). Briefly, the transfected cells were washed with PBS and harvested by trypsinization. Cells were recovered by centrifugation at 1,000 rpm for 5 min at room temperature, and the pellet was resuspended in 1 ml PBS. Transfection efficiency was quantified and expressed as percentage of EGFP-expressing cells using a flow cytometer with Cell Quest software (Becton-Dickinson FACS Vantage, San Jose, CA). The transfection efficiency of rat islets was determined by counting the number of the fluorescent positive islets and total islets in the same microscopic field. A minimum of 50 islet cells was counted in quadruplicate in each experimental group.
Measurement of cell viability
Flow cytometry analysis. Viability after transfection was assessed using 7-amino actinomycin D (7-AAD, Sigma) to determine the percentage of dead cells by flow cytometry as described above.
Acridine orange/Propidium iodide fluorescent staining. Islet viability was also evaluated by fluorescent staining with acridine orange/propidium iodide (AO/PI) (Sigma, St. Louis, MO). An AO/PI stock solution was prepared with 0.67 μM AO and 75 μM PI in PBS. Aliquots of the islets were mixed with 190 μl of AO/PI stock solution. Islets fluorescing green were regarded as viable. Islets fluorescing orange, either fully or partially, were regarded as nonviable.
In vitro transfection and hypoxia-inducible vascular endothelial growth factor (VEGF) expression assay.
The construction of pSV-VEGF and pRTP801-VEGF was described previously (13) . Effectene was used as a gene carrier. Transfection conditions of Effectene/pSV-VEGF or pRTP-VEGF were optimized according to the manufacturer's instructions. The amount of plasmid was fixed at 1 mg/well and the complexes were added to each well (n=4). The rat islets were then incubated at 37˚C in a 5% CO 2 incubator. After 4 h, the transfection mixtures were removed and 100 μl of fresh Medium 199 containing 10% FBS was added. Cells were incubated at the desired concentration of oxygen (normoxia, 20% oxygen; hypoxia, 1% oxygen) for 12 h. ELISA was performed using a Biosource Human Vascular Endothelial Growth Factor ELISA kit (Biosource International Inc., Camarillo, CA) (14) .
Statistical analysis. Statistical analysis was performed using the PRISM (GraphPad Software Inc, San Diego, CA). Results are expressed as means ±SD. The one-way analysis of variance (ANOVA) was used for comparisons involving more than two groups. Statistical significance was defined by convention as a p-value <0.05.
Results
Transfection efficiency measurements. Transfection efficiencies were determined for three non-viral vectors using pCMV-Luc and pEGFP-C1, and rat INS-1 cells and rat islets.
Rat INS-1 cells. First, the transfection efficiency was assessed by luciferase activity. Effectene showed the highest transfection efficiency among the non-viral carriers. HVJ-E was the least effective transfection carrier. The efficiency of Effectene (6.47x10 7 ±1.46x10 7 RLU/mg) was significantly higher than that of 25-kDa PEI (2.44x10 7 ±8.1x10 7 RLU/mg) and HVJ-E (5.77x10 3 ±3.69x10 3 RLU/mg) (p<0.001 for both, Fig. 1a) .
Second, the transfection efficiency was assessed by GFP expression. A negligible number of GFP positive cells were observed in the cells transfected with HVJ-E (Fig. 1b) . In flow cytometric counting of GFP positive cells, Effectene was significantly more effective than PEI (p<0.0001 for Effectene vs. 25-kDa PEI), with GFP expression ranging from 32.6 to 41.6% (32.6% in 1 μg, 36.6% in 2 μg, and 41.6% in 4 μg, p=0.16). For PEI, expression ranged from 1.0 to 7.5% (1.0 % in 1 μg, 3.8% in 2 μg, and 7.5% in 4 μg). P-values for 1 μg vs. 2 and 4 μg were <0.05 and 0.01, respectively. For 2 μg vs. 4 μg, p<0.05 (Fig. 1c) .
Rat islets. Fig. 2 shows rat islets transfected with pEGF-C1 using Effectene, PEI, and HVJ-E. Compared with 25-kDa PEI, the Effectene showed significantly higher transfection efficiency in rat islet cells (p<0.001, Effectene vs. PEI). The percentages of GFP-positive islets from 50 Effectenetransfected islets were 50.5±9.6, 54.0±19.1 and 61.0±17.5% for 1, 2, and 4 μg DNA equivalents, respectively (p=0.65). The percentages of GFP-positive islets from 50 PEI-transfected islets were 25.3±4.8, 27.0±9.6 and 30.5±8.7% using 1, 2, and 4 μg DNA equivalents, respectively (p=0.65).
Effects of transfection on cell viability. For the determination of cytotoxicity, composition and preparation of transfection complexes and conditions were the same as those used in the efficiency experiments.
Rat INS-1 cells. Flow cytometry for 7-AAD showed the cytotoxicity of Effectene (7.4-8.2%) was similar to that of 25-kDa PEI (6.9-8.4%, Fig. 3a) . (Fig. 3b) showed that both Effectene/plasmid and PEI/plasmid complexes were minimally toxic to rat islets.
Rat islets. AO/PI staining

Hypoxic-inducible VEGF expression.
Rat islets were transfected with pSV-VEGF and pRTP801-VEGF and incubated under normoxia or hypoxia conditions for 20 h. In pSV-VEGF, VEGF expression was regulated by the SV40 promoter. In pRTP801-VEGF, VEGF expression was under the control of the RTP801 promoter, which is a hypoxia inducible promoter. The VEGF was significantly induced in the islets transfected with pRTP801-VEGF under hypoxia conditions (Fig. 4) . This effect was not observed in the islets transfected with pSV40-VEGF, suggesting that the RTP801 promoter increased VEGF expression specifically in islets under hypoxia.
Discussion
Synthetic delivery systems have been investigated as an alternative to viral vectors because they raise fewer safety issues, are easier to produce, and pose fewer problems for repeated administration than viral gene transduction (15) . The variability in transfection efficiencies for non-viral delivery systems in vitro and in vivo, especially in primary cells, might be dependent on transfected cell types, delivery system, size of the transfection system, or the ratio of DNA to reagent (16) . Transfection into pancreas islet cells is difficult because islets have an extracellular matrix (17) and are static, with a low proliferative rate (18) . This is especially true in cultured pancreatic islets, which exist as spheroidal clusters of 1,000-2,000 cells that are difficult to transfect by physical methods (19) . Many other factors in the optimization of non-viral gene transfer are still poorly understood and require further investigation, especially with pancreatic islet cells. In this study, we performed a comparative analysis of the transfection efficiency and cytotoxicity of clinically applicable non-viral vectors that are candidates for islet gene therapy, and optimized transfection conditions into pancreatic islet cells. PEI is a highly charged cationic organic polymer containing amino nitrogen at every third carbon. It is one of the most widely used non-viral gene carriers (20) (21) (22) . The high transfection efficiency of PEI is due to the proton sponge effect, which facilitates endosomal escape of PEI/DNA complexes. PEI is also easily modified by conjugation to targeting moieties or other functional groups. PEI has different transfection efficiencies, depending on its molecular weight and the form of PEI. In this study, branched 25-kDa PEI was compared with other non-viral vectors for transfection into the pancreatic ß-cells based on a previous report that the efficiency of 25 kDa branched PEI was significantly higher than that of a PAMAM dendrimer or 2 kDa linear PEI (14) . Hemagglutinating virus of Japan envelope (HVJ-E, an inactivated Sendai virus envelope) was reported to be useful and efficient as a non-viral vector for gene delivery (23) . HVJ-E incorporates a variety of molecules (DNA, RNA, proteins, and drugs) and delivers them into mammalian cells via membrane fusogenic activity. Although the HVJ-E vector was widely adopted as a gene transfection reagent in diverse cells, to our knowledge, there are no published reports of gene transfection into pancreatic islets. Effectene reagent is a synthetic cationic non-liposomal lipid formulation that is used in conjunction with a special DNA-condensing enhancer and an optimized buffer to achieve high transfection efficiencies (24) . The enhancer first condenses the DNA molecules, and Effectene subsequently coats them with cationic lipids, providing a particularly efficient way of transferring DNA into eukaryotic cells. We previously demonstrated the superiority of non-liposomal lipid Effectene reagent over the liposomal lipid Lipofectamine for highefficiency gene transfer into isolated pancreatic islets in culture (4) . For these reasons, we used 25 kDa branched-PEI, HVJ-E, and Effectene to represent different classes of non-viral gene delivery system in this study.
The efficiency of the PEI and Effectene vectors was dependent on the DNA/carrier ratio within the range of 1-4 μg DNA. In the range of 1-4 μg DNA of pEGFP-C1/Effectene or 25-kDa PEI, the DNA dose did not significantly affect the cytotoxicity. Our transfection results using dividing rat INS-1 cells and non-dividing rat pancreas islets showed that Effectene was more efficient than other non-viral vectors.
The viability of transplanted islets decreases with time, which is in part due to hypoxia after transplantation. Previously, it was shown that delivery of VEGF to islets using adenovirus or Effectene vector increased the survival of transplanted islets (4, 25) . However, VEGF poses a safety problem for clinical applications, since it induces overgrowth of endothelial cells and hemangioma (12, 26) . Therefore, regulation of VEGF gene expression is crucial for VEGF gene transfer. Using the secretory VEGF peptide, rat islets were transfected with pSV-and pRTP801-VEGF using Effectene reagent, and the transfected islets were incubated under normoxia or hypoxia conditions for 20 h. VEGF was induced in the hypoxic islets transfected with pRTP801-VEGF. This effect was not observed in islets transfected with pSV40-VEGF, however, suggesting that the RTP801 promoter increased VEGF expression specifically in islets under hypoxia. This finding was in accordance with our previous report using PEI as a gene carrier (14) .
Non-viral vectors are far less efficient than viral vectors for gene transfection into pancreatic islets. This is acceptable, however, depending on the target gene chosen. Overexpression of a therapeutic secretory peptide by a small portion of islet cells may be sufficient for some therapeutic aims of islet transplantation (1,4). Our results provide useful information for optimizing transfer conditions using non-viral vectors in human islet transplantation trials. In summary, we investigated the prospects of non-viral vectors for gene delivery and demonstrated that Effectene formulations transfer genes with relatively high efficiency and low cytotoxicity to the pancreatic islets. Figure 4 . VEGF expression by pSV-VEGF or pRTP801-VEGF. pSV-VEGF/ Effectene or pRTP801-VEGF/Effectene complexes were transfected into rat islets. The islets were exposed to normoxia or hypoxia for 20 h. The expression of VEGF was measured by ELISA. * p<0.05 as compared with normoxia.
